Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-20 / J. Dermatol. Sci. 2009 Apr;54(1):31-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-20 / J. Dermatol. Sci. 2009 Apr;54(1):31-72009-01-20 00:00:002019-02-15 08:49:30Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-47https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-16 / Cell Death Differ. 2009 Apr;16(4):638-472009-01-16 00:00:002019-02-15 09:17:36Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-15 / Cancer 2009 Jan;115(2):311-23https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-15 / Cancer 2009 Jan;115(2):311-232009-01-15 00:00:002019-02-15 09:17:38Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-52https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-12 / J. Clin. Oncol. 2009 Feb;27(6):945-522009-01-12 00:00:002019-02-15 08:49:55Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-67https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-09 / Immunol. Lett. 2009 Jan;122(1):58-672009-01-09 00:00:002019-02-15 08:44:28Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):25-82009-01-01 00:00:002019-02-15 08:38:02Recent advances in cancer immunotherapy with an emphasis on vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-66https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Expert Rev Vaccines 2009 Jan;8(1):51-662009-01-01 00:00:002021-11-15 17:02:36Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Hepatology 2009 Jan;49(1):124-32https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Hepatology 2009 Jan;49(1):124-322009-01-01 00:00:002020-01-08 10:10:21A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Electromagn Biol Med 2009;28(2):148-65https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Electromagn Biol Med 2009;28(2):148-652009-01-01 00:00:002019-02-15 09:17:31Oncothermia treatment of cancer: from the laboratory to clinic
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Cell. Immunol. 2009;257(1-2):23-31https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Cell. Immunol. 2009;257(1-2):23-312009-01-01 00:00:002019-02-15 08:50:13Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Klin Onkol 2009;22(2):67-72https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Klin Onkol 2009;22(2):67-722009-01-01 00:00:002019-02-15 08:50:58[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002009-01-01 / Recent Results Cancer Res. 2009;179:301-19https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2009-01-01 / Recent Results Cancer Res. 2009;179:301-192009-01-01 00:00:002009-01-01 00:00:00Current concepts in the management of retroperitoneal soft tissue sarcoma
Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis
Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70
Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death
Immunotherapy in acute leukemia
New therapeutic strategies in acute lymphoblastic leukemia
Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications
Recent advances in cancer immunotherapy with an emphasis on vaccines
Randomized clinical studies of anti-tumor vaccination: state of the art in 2008
Tumour vaccine approaches for CNS malignancies: progress to date
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
Oncothermia treatment of cancer: from the laboratory to clinic
Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro
Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
[The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells]
Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma – comparison with preventive anti-tumour vaccination
Current concepts in the management of retroperitoneal soft tissue sarcoma